News Release

20/01/2010

ONCOLOGY: PALONOSETRON APPROVED IN JAPAN, SECOND PHARMACEUTICAL MARKET WORLDWIDE

03/08/2009

Taiho to Buy Tsukuba Research Institute from Banyu

21/07/2009

TS-1 Approved in Singapore

31/03/2009

Taiho and PharmaMar (Spain) enter into a license agreement on antitumor agent

11/03/2009

Initiation of co-development of a β3-adrenoceptor agonist

01/10/2008

Basic agreement reached with Nippon Shinyaku for the collaborative development and marketing of a new antipruritic agent (code NS-141)

01/10/2008

Domestic manufacture of downsized Uzel (calcium folinate) 25 mg tablets to be started soon

01/10/2008

Autumn 2008 version TV commercial for Tiovita Drink is aired

30/09/2008

Zosyn, a new injectable combination antibiotic of beta-lactamase inhibitor and penicillin domestically launched on October 1

30/09/2008

Taiho Pharmaceutical collaborates with and supports the Japan Pink Ribbon Campaign for this year

29/09/2008

46th fiscal-year (07/2007- 06/2008) report is released

22/09/2008

New website contents to promote medical check-ups for breast cancer are released

02/09/2008

The antipsoriatic ethical drugs, Urepearl-Plus Lotion 10 and Urepearl-Plus Cream are launched on September 3

20/08/2008

8th Oncology Media Seminar is held: Main topic - Current therapyfor breast cancer

25/07/2008

Notice: Three Otsuka group companies (Otsuka Pharmaceutical Factory, Otsuka Warehouse, and Taiho Pharmaceutical) are reorganized as wholly-owned direct subsidiaries

18/07/2008

License agreement with Sanofi-Aventis on TS-1 is terminated

18/07/2008

Results of a randomized comparative phase 3 study of S-1 in advanced/recurrent gastric cancer become available

16/07/2008

Notice: Acquisition of manufacturing/distribution license for Zosyn, a new injectable combination antibiotic of beta-lactamase inhibitor and penicillin

24/06/2008

Summer 2008 version TV commercial for Tiovita Drink is aired

07/04/2008

7th Oncology Media Seminar is opened: Main topic - Gastric cancer: Clinical studies of oral anti-gastric cancer agents and guidelines for the treatment of gastric cancer

25/03/2008

Results of a randomized comparative study of S-1 monotherapy compared to S-1 with cisplatin (SPIRITS trial) in advanced/recurrent gastric cancer is published in Lancet Oncology: New standard therapy for advanced gastric cancer anticipated

18/01/2008

Spring 2008 version TV commercial for Tiovita Drink is aired